In order to initially validate the impact of our aging-related prognostic scoring system on major T cell subsets, we measured the relative expression levels of six target genes in two NB cell lines with different MYCN amplification, as depicted in Figures 7A–F. This evidence concerns the gene MYCN and neuroblastoma.